• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制性胶原蛋白受体LAIR-1(CD305)。

The inhibitory collagen receptor LAIR-1 (CD305).

作者信息

Meyaard Linde

机构信息

Department of Immunology, University Medical Center, Utrecht 3584 EA, The Netherlands.

出版信息

J Leukoc Biol. 2008 Apr;83(4):799-803. doi: 10.1189/jlb.0907609. Epub 2007 Dec 6.

DOI:10.1189/jlb.0907609
PMID:18063695
Abstract

The immune system protects the body from invaders such as viruses and bacteria. Immune cells must be activated in the correct context to function properly. It is critical that the receptors, costimulatory molecules, and cytokines that orchestrate this activation are carefully regulated to prevent uncontrolled inflammation and autoimmunity. Inhibitory receptors play an important role in regulation of immune cell function, usually upon interaction with ligands present on other cells. In contrast, the function of the inhibitory leukocyte-associated Ig-like receptor (LAIR)-1 can be regulated by extracellular matrix collagens. LAIR-1 is expressed on most cells of the immune system, and its function has been studied on multiple cell types. This review summarizes current literature about LAIR-1, a receptor that potentially is able to regulate multiple steps of an immune response.

摘要

免疫系统保护身体免受病毒和细菌等入侵者的侵害。免疫细胞必须在正确的环境中被激活才能正常发挥功能。协调这种激活的受体、共刺激分子和细胞因子必须受到严格调控,以防止不受控制的炎症和自身免疫。抑制性受体通常在与其他细胞上存在的配体相互作用时,在免疫细胞功能的调节中发挥重要作用。相比之下,抑制性白细胞相关免疫球蛋白样受体(LAIR)-1的功能可由细胞外基质胶原蛋白调节。LAIR-1在免疫系统的大多数细胞上表达,并且已经在多种细胞类型上研究了其功能。本综述总结了关于LAIR-1的当前文献,LAIR-1是一种可能能够调节免疫反应多个步骤的受体。

相似文献

1
The inhibitory collagen receptor LAIR-1 (CD305).抑制性胶原蛋白受体LAIR-1(CD305)。
J Leukoc Biol. 2008 Apr;83(4):799-803. doi: 10.1189/jlb.0907609. Epub 2007 Dec 6.
2
Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation.人外周血T细胞活化和分化过程中抑制性受体LAIR-1的表达调控
Eur J Immunol. 2007 Apr;37(4):914-24. doi: 10.1002/eji.200636678.
3
Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells.白细胞相关免疫球蛋白样受体-1在细胞毒性T细胞上作为一种抑制性受体发挥作用。
J Immunol. 1999 May 15;162(10):5800-4.
4
Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1.肿瘤表达的胶原可以通过抑制性胶原受体 LAIR-1 调节免疫细胞功能。
Mol Immunol. 2011 Oct;49(1-2):402-6. doi: 10.1016/j.molimm.2011.09.006. Epub 2011 Sep 28.
5
Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.胞质酪氨酸氨基端的保守残基有助于杀伤细胞免疫球蛋白样受体的SHP-1介导的抑制功能。
J Immunol. 1999 Jan 15;162(2):897-902.
6
Cell surface expression of channel catfish leukocyte immune-type receptors (IpLITRs) and recruitment of both Src homology 2 domain-containing protein tyrosine phosphatase (SHP)-1 and SHP-2.沟鲶白细胞免疫型受体(IpLITRs)的细胞表面表达以及含Src同源2结构域的蛋白酪氨酸磷酸酶(SHP)-1和SHP-2的募集。
Dev Comp Immunol. 2009 Apr;33(4):570-82. doi: 10.1016/j.dci.2008.10.006. Epub 2008 Nov 12.
7
Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1.胶原蛋白是抑制性免疫受体LAIR-1的功能性高亲和力配体。
J Exp Med. 2006 Jun 12;203(6):1419-25. doi: 10.1084/jem.20052554. Epub 2006 Jun 5.
8
Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.杀伤细胞抑制性受体抑制细胞活化过程中基于免疫受体酪氨酸的抑制基序N端和C端的不同作用
J Immunol. 1999 Mar 15;162(6):3168-75.
9
LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes.LAIR-1,一种在人类单核白细胞上表达的新型抑制性受体。
Immunity. 1997 Aug;7(2):283-90. doi: 10.1016/s1074-7613(00)80530-0.
10
Paired inhibitory and activating receptor signals.配对的抑制性和激活性受体信号
Rev Immunogenet. 2000;2(2):204-19.

引用本文的文献

1
Targeting LAIR1-mediated immunosuppression adds a new weapon to our immunotherapy arsenal.靶向LAIR1介导的免疫抑制为我们的免疫治疗武器库增添了新的武器。
J Clin Invest. 2025 Aug 15;135(16). doi: 10.1172/JCI194924.
2
Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review).人类恶性肿瘤中的癌症相关成纤维细胞,尤其侧重于肉瘤(综述)
Int J Oncol. 2025 Oct;67(4). doi: 10.3892/ijo.2025.5785. Epub 2025 Aug 8.
3
Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review.
癌症相关成纤维细胞在癌症耐药性和癌症进展中的作用:综述
Cell Death Discov. 2025 Jul 24;11(1):341. doi: 10.1038/s41420-025-02566-x.
4
Collagen in pituitary adenomas: A comprehensive review of biological roles and clinical implications.垂体腺瘤中的胶原蛋白:生物学作用与临床意义的全面综述
J Clin Transl Endocrinol. 2025 Jul 10;41:100408. doi: 10.1016/j.jcte.2025.100408. eCollection 2025 Sep.
5
The Role of LAIR1 as a Regulatory Receptor of Antitumor Immune Cell Responses and Tumor Cell Growth and Expansion.LAIR1作为抗肿瘤免疫细胞反应以及肿瘤细胞生长与增殖的调节性受体的作用。
Biomolecules. 2025 Jun 13;15(6):866. doi: 10.3390/biom15060866.
6
Immune inhibitory receptor agonist therapeutics.免疫抑制受体激动剂疗法。
Front Immunol. 2025 Mar 26;16:1566869. doi: 10.3389/fimmu.2025.1566869. eCollection 2025.
7
Polymerized Type I Collagen Downregulates STAT-1 Phosphorylation Through Engagement with LAIR-1 in Circulating Monocytes, Avoiding Long COVID.聚合的I型胶原蛋白通过与循环单核细胞中的LAIR-1结合来下调STAT-1磷酸化,从而避免长期新冠症状。
Int J Mol Sci. 2025 Jan 25;26(3):1018. doi: 10.3390/ijms26031018.
8
The dysadherin/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression.黏着斑失活蛋白/MMP9 轴改变细胞外基质从而加速结直肠癌进展。
Nat Commun. 2024 Nov 30;15(1):10422. doi: 10.1038/s41467-024-54920-9.
9
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?调节胶质母细胞瘤浸润性髓样细胞上的免疫检查点是否是一种可行的治疗策略?
Neuro Oncol. 2025 Jan 12;27(1):33-49. doi: 10.1093/neuonc/noae193.
10
LAIR-1 and PECAM-1 function via the same signaling pathway to inhibit GPVI-mediated platelet activation.LAIR-1和PECAM-1通过相同的信号通路发挥作用,以抑制糖蛋白VI(GPVI)介导的血小板活化。
Res Pract Thromb Haemost. 2024 Aug 23;8(6):102557. doi: 10.1016/j.rpth.2024.102557. eCollection 2024 Aug.